Lucentis and Avastin perform similarly to Eylea when vision loss is mild, NIH study shows Bethesda, Maryland–(ENEWSPF)–February 19, 2015.  In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was[Read More…]

NIH-funded network study finds risk even for women with no history of depression Bethesda, Maryland–(ENEWSPF)–February 19, 2015.  Women who deliver a stillbirth — but who have no history of depression — may be at a higher risk for long-lasting depression, conclude researchers funded by the National Institutes of Health (NIH).[Read More…]

Following GMO apple approval, consumer watchdog groups highlight need for accurate media coverage on GMO science WASHINGTON, D.C. –(ENEWSPF)—February 19, 2015. On the heels of USDA deregulation of the Arctic® apple — the first genetically engineered apple — leading consumer, food safety and environmental groups issued a response to widespread[Read More…]

Findings point to potential drug targets Bethesda, Maryland–(ENEWSPF)–February 17, 2015. Investigators with the National Institutes of Health have discovered the genomic switches of a blood cell key to regulating the human immune system. The findings, published in Nature today, open the door to new research and development in drugs and[Read More…]

OREGON–(ENEWSPF)–February 17, 2015 Written by Jen Keehn The number of people with intolerance to gluten has been steadily rising, and the sheer number of people that need to follow a “gluten free” diet is a little bit scary. A lot of people are beginning to question why there’s such a sweeping surge in[Read More…]

Patients praise common sense regulatory solution introduced in House, Senate hearing Tuesday on bill to add PTSD as qualifying condition Olympia, WA –(ENEWSPF)—February 16, 2015. Medical cannabis patients are applauding the introduction of a bipartisan bill in the House that would fully restore vetoed provisions of a regulatory proposal first[Read More…]

OREGON–(ENEWSPF)–February 16, 2015.  Illinois’ medical marijuana industry is off to a rough start. It took longer than expected for the State of Illinois to issue medical marijuana business licenses. The process was largely shrouded in mystery, with accusations about the process being unfair being hurled early and often. Now that[Read More…]

OREGON–(ENEWSPF)–February 16, 2015.  Illinois’ medical marijuana industry is off to a rough start. It took longer than expected for the State of Illinois to issue medical marijuana business licenses. The process was largely shrouded in mystery, with accusations about the process being unfair being hurled early and often. Now that[Read More…]

Silver Spring, Maryland–(ENEWSPF)–February 13, 2015.  Documents include draft guidances on outsourcing facility registration; outsourcing facility adverse event reporting; drug repackaging; mixing, diluting, and repackaging biological products; and a draft Memorandum of Understanding with the states Today, the U.S. Food and Drug Administration issued five draft documents related to drug compounding[Read More…]

Silver Spring, Maryland–(ENEWSPF)–February 13, 2015.  The U.S. Food and Drug Administration today granted approval to Lenvima (lenvatinib) to treat patients with progressive, differentiated thyroid cancer (DTC) whose disease progressed despite receiving radioactive iodine therapy (radioactive iodine refractory disease). The most common type of thyroid cancer, DTC is a cancerous growth[Read More…]